Newleos Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Newleos Therapeutics's estimated annual revenue is currently $1.1M per year.
- Newleos Therapeutics's estimated revenue per employee is $140,000
Employee Data
- Newleos Therapeutics has 8 Employees.
- Newleos Therapeutics grew their employee count by 700% last year.
Newleos Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founding CEO | Reveal Email/Phone |
2 | Co-founder, Chief Medical Officer | Reveal Email/Phone |
3 | Co-founder, start-up Chief Development Officer | Reveal Email/Phone |
4 | Co-founder, Head Strategy & Operations | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | VP, Finance | Reveal Email/Phone |
What Is Newleos Therapeutics?
We are dedicated to providing a new dawn or "eos" for patients with mental health conditions by developing next generation, first- and best-in-class therapies. Over 100 million patients in the United States are affected by neuropsychiatric disorders, with anxiety and substance use disorders among the largest areas of unmet medical need. Our clinical-stage pipeline was licensed from Roche and includes oral small molecules targeting GABAA-γ1, V1a, TAAR1 and GABAA-α5 with broad potential in general anxiety, social anxiety, substance use disorders and cognitive impairment. Newleos was co-founded by Longwood Fund, Federico Bolognani, M.D., Ph.D., and William Martin, Ph.D., seasoned experts in company creation and CNS drug development.
keywords:N/A
N/A
Total Funding
8
Number of Employees
$1.1M
Revenue (est)
700%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 8 | -20% | N/A |
#2 | $0.8M | 8 | N/A | N/A |
#3 | $0.1M | 8 | 0% | $22.2M |
#4 | $0.8M | 8 | N/A | N/A |
#5 | $0.8M | 8 | N/A | N/A |